Innovation
147 patent families (67 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 7,701 times.
| Year | Filings |
|---|---|
| 2015 | 24 |
| 2016 | 16 |
| 2017 | 16 |
| 2018 | 18 |
| 2019 | 38 |
| 2020 | 45 |
| 2021 | 20 |
| 2022 | 11 |
| 2023 | 20 |
| 2024 | 19 |
| 2025 | 17 |
| 2026 | 7 |
Social engagement
Social engagement: 13.1K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
8 investors on record; lead investors include Bioam, Idinvest Partners, Smalt Capital, CDC Enterprises; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 13% |
| Private equity | 1 | 13% |
| Bank & private debt | 4 | 50% |
| Other / undisclosed | 2 | 25% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
25 Feb 2026 · Stage en développement Pharmaceutique H.F · Lyon
5 May 2025 · Technicien Physico-chimiste / Formulation en contrat d'apprentissage H/F · Lyon
Based on job postings tracked across public sources.
Recent activity
15 Jun 2026
Event
Virtual KOL event on BioChaperone® Lispro Phase 3 results in people with Type 2 Diabetes in China
5 Jun 2026
Event
2nd Annual Obesity & Cardiometabolic Innovation Forum
4 Jun 2026
Event
Scientific Sessions of the American Diabetes Association (ADA) 2026